Publication | Closed Access

Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation

TransplantationCardiovascular DiseaseSolid Organ TransplantationImmunologyHepatitisDonor Hepatitis-c SeropositivityCardiologyGraft SurvivalTransplant ArteriopathyCardiac TransplantationMedicineAtherosclerosisAccelerated Coronary Vasculopathy